Professor Alex Richter
@AlexRichter3
Followers
4K
Following
4K
Media
275
Statuses
3K
Director of the Clinical Immunology Service, University of Birmingham. Consultant Clinical Immunologist University Hospitals Birmingham.
Joined July 2012
Excited to share our work on Pregnancy Loss at the 3rd Birmingham Translational Research Symposium! @unibirm_TRT #UoB_TRS2025
0
2
5
🚨 Registration is now open for the BSI-CIPN Conference 2025! Join clinical immunology professionals in Liverpool this December for cutting-edge science, practical insights & expert-led discussions #BSICIPN25 🔗 Save with early bird & member discounts! https://t.co/ghNicXDu2O
0
5
2
So excited to have been shortlisted for this 👇Thank you to whoever nominated me :) It’s a public vote so grateful to all those who vote!
1
2
14
@AlexRichter3 Great to see this study published. The dried blood spot experience must have opened up valuable lessons for how we approach testing under pressure really insightful
0
1
1
📣Professor @AlexRichter3 presenting "Testing times: developing diagnostics to meet contemporary healthcare challenges" @bsicongress @ImmunologyUoB @BSI_Midlands @unibirmingham @BSI_CIPN
0
4
16
Excited to be in Sheffield today highlighting dilemmas for immune vulnerable when it comes to measles and MMR live vaccine #UKCVN2025
0
0
10
Multi disciplinary discussion on early stage T1D - so much still to work out and learn with immunotherapy hopefully coming soon to modulate diabetes progression
#EarlyT1Dsummit Amazing overview of the next steps for POC islet antibody testing from @AlexRichter3 @elsadiabetes @parthnarendran
0
0
3
👇STRAVINSKY is the largest most comprehensive study of immunity across 20 clinically vulnerable groups. Thank you to all our participants and looking forward to sharing our results in the autumn in our public webinar 🙏 @ResearchFIRSTB
🎉 Big milestone! @STRAVINSKYstudy wraps up patient activities. We supported with 📦 Shipping kits 👥 Supporting 2,695 patients 🧠 Managing data & building REDCap Our work continues with data cleaning to ensure quality insights. Huge thanks to @AlexRichter3 for the trust !
0
2
10
Great to finally get this paper out! The DBS assay has been the bedrock of the ELSA screening program and this paper demonstrates user acceptability and lab accuracy. @DUK_research @BT1DUK @elsadiabetes
DBS is a reliable, accepted method for early type 1 diabetes screening in the community! @Dr_LaurenQuinn @parthnarendran @AlexRichter3 @elsadiabetes
0
8
25
Delighted to publish our validation of T1D antibodies using dried blood spot sampling🩸 https://t.co/LoR9IpBAU4
Establishing the performance and acceptability of dried blood spot sampling to screen for islet‐specific autoantibodies - Faustini - Diabetic Medicine - Wiley Online Library
7
2
9
Just getting ready for our spring webinar this evening. ✔️ Update on @STRAVINSKYstudy ✔️Beyond Covid - other infection risks ✔️From research to impact
Remember to register for our free public webinar, providing an update on our work on which groups are most clinically vulnerable to COVID-19 👤Speaker: @AlexRichter3 🗓️Tues 6 May, 18:00-19:00 BST 🔗Register:
1
1
7
Representing @BSI_CIPN for a #WorldImmunisationWeek parliamentary event to highlight the importance of including immune-vulnerable groups in #vaccine clinical trials. Showed data from @STRAVINSKYstudy reporting later this year on value of biomarkers as a risk of severe infection
3
6
20
I had wonderful opportunity to highlight the importance of vaccination for the immune vulnerable and the need for global access at an affordable price for the vaccine and its delivery #worldimmunisationweek @BactiVac @UoBinfectionsch @CISUoB
Today we've been at the #WorldImmunisationWeek parliamentary event with @resultsuk to highlight the importance of including immune-vulnerable groups in #vaccine clinical trials. A big thank you to everyone who spoke to us to share their valuable perspectives! 🙂
0
3
7
Excited to be preparing for our next public webinar with updates on @STRAVINSKYstudy and an update on wider infection risk in clinically vulnerable patients 👇 Let me know if any burning qs
Remember to register for our free public webinar, providing an update on our work on which groups are most clinically vulnerable to COVID-19 👤Speaker: @AlexRichter3 🗓️Tues 6 May, 18:00-19:00 BST 🔗Register:
0
1
2
Great to be able to contribute to this publication. How do we rethink diagnostics to reduce cost and increase access 🧐👇
#WorldImmunizationWeek | Prof @AlexRichter3 explains the importance of effective diagnostics in the Global South and @unibirmingham development of low-cost tests for infectious and non-communicable diseases, helping support vaccine delivery. https://t.co/4K2Xk7wEN4
@MediaplanetUK
0
1
4
3
3
33
Are you aged 18–25, from a minority ethnic background, and living with type 1 diabetes? Your lived experience can help make diabetes tech more inclusive. Join a 2-hour online session to share how research findings should be shared — and get £50 for your time. 💬 🔗 Fill out the
0
6
4
👇@DocSteveTaylor recruiting women for a #HIV prevention study. He led amazing work to expand viral testing in a&e with universal testing unless opt out 🙌 Prevention and early detection ✔️
Volunteers wanted for an exciting new Study! Do you live in or around Birmingham? Are you a sexually active woman? This #HIV Prevention study may well be for you … find out more @healthybrum @BSol_ICS @AduduTrish @Beverleyknight @ichoosemag @unibirmingham
0
0
1
🩸 Researchers from @CISUoB – a PHTA anchor resident – have received £230k of translational funding from @CR_Horizons to develop a prototype for a new test to monitor people at risk of developing the blood cancer multiple myeloma 👇 https://t.co/PskTfRGyI6
@AlexRichter3
0
4
5
👇Amazing opportunity
🔈 Calling all entrepreneurs- application are now open for UoB Elevate, an incubator and business growth programme exclusive to @unibirmingham students and graduates, located at the Exchange in Birmingham City Centre. Find out more and apply before 22 June
0
0
1